ASBP (Aspire Biopharma Holdings, Inc. Common Stock) Stock Analysis - Analyst Ratings

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of May 21, 2026, ASBP trades at $5.98 with a market cap of $8.09M and a P/E ratio of 0.00. ASBP moved +2.06% today. Year to date, ASBP is -95.82%; over the trailing twelve months it is -97.91%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ASBP?

The average price target is $0.00.

ASBP Key Metrics

Key financial metrics for ASBP
MetricValue
Price$5.98
Market Cap$8.09M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$11,832.00
52-Week Low$3.31
Volume3.00K
Avg Volume0
Revenue (TTM)$6.20K
Net Income$-24.48M
Gross Margin0.00%

ASBP Analyst Consensus

ASBP analyst coverage data. Average price target: $0.00.

Latest ASBP News

Recent ASBP Insider Trades

  • Fell Donald G. bought 10.50K (~$4.09K) on Jun 5, 2025.
  • Fell Donald G. sold 10.50K (~$4.09K) on Jun 5, 2025.
  • Fell Donald G. bought 9.50K (~$3.71K) on Jun 4, 2025.

Common questions about ASBP

What do analysts rate ASBP?
The average price target is $0.00.
Does Rallies show ASBP price targets?
Yes. Rallies tracks ASBP analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ASBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.
ASBP

ASBP